DiviDrip · IMMX

IMMX — Immix Biopharma, Inc.

IMMX is Immix Biopharma, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $13.96. Market cap: $997M. Capital Quality Rank: 54/100 — Above average.

Stock snapshot

Price$13.96
Market cap$997M
SectorHealthcare
ExchangeNCM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)54 / 100 · Above average
Shareholder buyback yield-14.20%
Altman Z-score zoneSafe

About IMMX

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

Listed2021Employees21HQLos Angeles, CASectorHealthcareWebsiteimmixbio.com

Related non-dividend companies

Other non-dividend stocks investors research alongside IMMX. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is IMMX's current stock price?

IMMX (Immix Biopharma, Inc.) is currently trading at $13.96.

Does IMMX pay a dividend?

IMMX (Immix Biopharma, Inc.) does not currently pay a regular dividend.

What is IMMX's Capital Quality Rank?

IMMX has a Capital Quality Rank of 54/100 — Above average. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track IMMX in DiviDrip

Add IMMX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-03. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow